Patni family’s pharma foray: Raay Neo looks at smaller cities, less expensive medicines

Patni family venture to price medicines 15-20 per cent lower and target ₹1,000 crore revenue in five years

Raay Neo Pharma, floated by the third generation of the Patni family, looks to build its branded generic drugs business in smaller towns and cities, pegging medicine prices 15-20 per cent less than t…